NeuPath Health Inc. NPTH.V
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 5.76% | -2.64% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.76% | -2.64% | |||
| Cost of Revenue | 4.98% | -2.69% | |||
| Gross Profit | 9.25% | -2.42% | |||
| SG&A Expenses | 7.55% | -26.81% | |||
| Depreciation & Amortization | 5.12% | -3.29% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.30% | -6.51% | |||
| Operating Income | 16.87% | 12,298.00% | |||
| Income Before Tax | 69.69% | 224.12% | |||
| Income Tax Expenses | -1,052.81% | 302.53% | |||
| Earnings from Continuing Operations | 333.32% | 213.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -25.89% | 11.71% | |||
| Net Income | 397.96% | 176.72% | |||
| EBIT | 16.87% | 12,298.00% | |||
| EBITDA | 12.34% | 70.00% | |||
| EPS Basic | 397.50% | 176.92% | |||
| Normalized Basic EPS | 22.22% | 280.00% | |||
| EPS Diluted | 397.50% | 176.92% | |||
| Normalized Diluted EPS | 20.93% | 272.00% | |||
| Average Basic Shares Outstanding | 0.07% | 0.14% | |||
| Average Diluted Shares Outstanding | 1.66% | 5.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||